✦ LIBER ✦

Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2

✍ Scribed by Fiona O'Reilly; Elizabeth Feldman; James Yangb; Patrick Hwu; Maria L. Turner

Book ID: 117845665
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 156 KB
Volume: 48
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2003.204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long term follow up of 50 patients with

Long term follow up of 50 patients with metastatic renal cell carcinoma treated with high dose i.v. interleukin. 2

✍ Libra, M.; Buonadonna, A.; Freschi, A.; Bearz, A.; Berretta, M.; Balestreri, L.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE I

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Walther, McClellan M.; Yang, James C.; Pass, Harvey I.; Linehan, W. Marston; Ros 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 499 KB

Prognostic markers for survival in patie

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

✍ Rutger L. van Bezooijen; H. Goey; Gerrit Stoter; J. Hermans; G. J. Fleuren 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 473 KB

High-dose interleukin-2 immunotherapy is

High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis

✍ JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Myositis associated with interleukin-2 t

Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma

✍ Francisco J. Esteva-Lorenzo; John E. Janik; Robert G. Fenton; Alison Emslie-Smit 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Initial Clinical Response Predicts Outco

Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2

✍ Kathryn Spanknebel; Kenneth Y. Cheung; John Stoutenburg; Karl Hurst-Wicker; Char 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 133 KB